๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

8524 Expression of BRAK/CXCL14 is associated with antitumor efficacy of gefitinib in head and neck squamous cell carcinoma

โœ Scribed by Hata, R.; Ozawa, S.; Kato, Y.; Ito, S.; Komori, R.; Shiiki, N.; Tsukinoki, K.; Maehata, Y.; Kubota, E.

Book ID
122389258
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
66 KB
Volume
7
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

E-cadherin expression in head and neck s
E-cadherin expression in head and neck squamous-cell carcinoma is associated with clinical outcome
โœ Vera Mattijssen; Pieter H. M. De Mulder; Herman M. Peters; Lia Schalkwijk; Bep V ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 871 KB

The cell-cell adhesion molecule E-cadherin has been shown to suppress invasive growth of epithelial cells in vitro, and loss of its expression is thought to be important in invasion and metastatic potential of epithelial tumors in vivo. We retrospectively studied the level of E-cadherin expression i

Efficacy of neck treatment in patients w
Efficacy of neck treatment in patients with head and neck squamous cell carcinoma
โœ Gabriela Buck; Pia Huguenin; Sandro J. Stoeckli ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 131 KB ๐Ÿ‘ 2 views

## Abstract ## Background. Treatment of head and neck squamous cell carcinoma (HNSCC) addresses the primary tumor and the lymphatic drainage. Modalities for the neck are neck dissection and/or radiation therapy. In most cases, the neck is treated by the modality that seems more appropriate for the